热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD69 Antibody
产品名称：
PE/Cyanine7 anti-mouse CD69 Antibody
产品类别：
抗体
产品编号：
104511
产品应用：
104511
[价格]
规格 价格 库存
25µg ￥ 924 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse dendritic epidermal T cell line Y245
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The H1.2F3 antibody has been reported to augment T cell activation. Additional reported applications (for the relevant formats) include: in vitro T cell and NK cell activation1-3, immunohistochemistry4,5, and immunoprecipitation1.

This antibody has been characterized in the literature as containing a lambda (?) light chain.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Yokoyama WM, et al. 1988. J. Immunol. 141:369. (IP)
  2. Sobel ES, et al. 1993. J. Immunol. 150:673.
  3. Karlhofer FM, et al. 1991. J. Immunol. 146:3662.
  4. Zhou X, et al. 2005. J. Biol. Chem. 280:31240. (IHC)
  5. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC)
  6. Lawson BR, et al. 2007. J. Immunol. 178:5366.
  7. Lee JW, et al. 2006. Nature Immunol. 8:181.
  8. Epardaud M, et al. 2008. Cancer Res. 15:2972. PubMed
  9. Jordan JM, et al. 2008. 76:3717. PubMed
  10. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  11. Ishikawa C, et al. 2013. Biochim Biophys Acta. 167:99. PubMed
Product Citations
  1. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  2. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  3. Oliver AJ, et al. 2020. Oncoimmunology. 9:1802979. PubMed
  4. Israelow B, et al. 2020. bioRxiv. . PubMed
  5. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  6. Redmann V, et al. 2016. Sci Rep. 6:23326. PubMed
  7. Muris A, et al. 2012. J Immunol Methods. 381:59. PubMed
  8. Bally AP, et al. 2017. J Immunol. 198:205. PubMed
  9. Wang L, et al. 2019. Cell Rep. 29:1848. PubMed
  10. Wilfahrt D, et al. 2021. Elife. 10:. PubMed
  11. Uhlig K, et al. 2015. J Virol. 89: 9044-9060. PubMed
  12. Christian LS, et al. 2021. Cell Reports. 35(6):109118. PubMed
  13. Wang D, et al. 2018. Immunity. 48:659. PubMed
  14. Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed
  15. Muthuswamy R, et al. 2021. J Immunother Cancer. 9:. PubMed
  16. Cannons JL, et al. 2021. Cell Rep. 37:109804. PubMed
  17. Manivasagam S, et al. 2022. J Immunol. 208:1341. PubMed
  18. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  19. Israelow B, et al. 2021. Sci Immunol. 6:eabl4509. PubMed
  20. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  21. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  22. Chung H, et al. 2021. Immune Netw. 21:e28. PubMed
  23. Sugimoto C, et al. 2022. Elife. 11:. PubMed
  24. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  25. Silva M, et al. 2021. Sci Immunol. 6:eabf1152. PubMed
  26. Müller M, et al. 2021. Nat Commun. 12:7036. PubMed
  27. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  28. Flommersfeld S, et al. 2021. Immunity. :. PubMed
  29. Cuburu N, et al. 2019. J Immunol. 202:1250. PubMed
  30. Nelson SA, et al. 2022. NPJ Vaccines. 7:124. PubMed
  31. Levescot A, et al. 2021. J Clin Invest. 131:. PubMed
  32. Yin Q, et al. 2021. Proc Natl Acad Sci U S A. 118: . PubMed
  33. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  34. Imani J, et al. 2021. JCI Insight. 6:. PubMed
  35. Reed J, et al. 2020. Bio Protoc. 10:e3607. PubMed
  36. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  37. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  38. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  39. Toomer K, et al. 2016. J Immunol. 196: 3665 - 3676. PubMed
  40. Liu Y, et al. 2017. Oncogene. 10.1038/onc.2017.209. PubMed
  41. Van Braeckel-Budimir N, et al. 2018. Cell Rep. 24:3374. PubMed
  42. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  43. Karandikar SH, et al. 2019. Anal Chem. 91:3405. PubMed
  44. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  45. Toshiro Hirai et al. 2019. Immunity. 50(5):1249-1261 . PubMed
  46. Mendelsohn AC, et al. 2020. Am J Physiol Cell Physiol. 319:C997. PubMed
  47. Isvoranu G, et al. 2019. Oncol Lett. 17:4197. PubMed
  48. Tsalavos S, et al. 2011. J Immunol. 186:6860. PubMed
  49. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  50. Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed
  51. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
  52. Mairhofer D, et al. 2015. J Invest Dermatol. 135: 2785-93. PubMed
  53. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  54. Liu Y, et al. 2020. Cell Death Dis. 11:1062. PubMed
  55. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  56. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  57. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  58. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  59. Qi H, et al. 2020. Cell Reports. 31(6):107621. PubMed
  60. Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed
  61. Agelidis A, et al. 2017. Cell Rep. 10.1016/j.celrep.2017.06.041. PubMed
  62. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  63. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  64. Chow AK, et al. 2021. Cellular and Molecular Gastroenterology and Hepatology. :. PubMed
  65. Gonzalez-Figueroa P, et al. 2021. Cell. 184(7):1775-1789.e19. PubMed
  66. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  67. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  68. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
  69. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
RRID
AB_493565 (BioLegend Cat. No. 104511) AB_493564 (BioLegend Cat. No. 104512)

Antigen Details

Structure
C-type lectin, 27/33 kD
Distribution

Activated T cells and B cells, NK cells, granulocytes, thymocytes, platelets

Function
Lymphocyte activation
Cell Type
B cells, Granulocytes, NK cells, Platelets, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Testi R, et al. 1994. Immunol. Today 15:479.
3. Moretta A, et al. 1991. J. Exp. Med. 174:1393.
4. Yokoyama WM, et al. 1988. J. Immunol. 141:369.

Gene ID
12515 View all products for this Gene ID
UniProt
View information about CD69 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线